When TCGA tumors were stratified by mutation and tumor type, both BRCA1 and BRCA2 germline mutation-associated breast and ovarian tumors had a significantly higher proportion of BRCA signature (Signature 3) compared to nonBRCA breast and ovarian tumors (Supplementary Fig. 2a, b). The gene discussed is BRCA2; the disease is ovarian neoplasm.